Apatinib Mesylate Tablets.

Apatinib mesylate tablets are suitable for patients with advanced gastric adenocarcinoma or gastroesophageal junction adenocarcinoma who have progressed or relapsed after at least two systemic chemotherapy treatments. Patients should be in good general condition during treatment.
Apatinib mesylate tablets are small molecule anti-angiogenic targeted therapeutic drugs that can inhibit the formation of new blood vessels in tumor tissues and achieve anti-tumor effects